Seamus Lagan - Rennova Health CEO and President and Director
| RNVADelisted Stock | USD 0.0001 0.00 0.00% |
CEO
Mr. Seamus Lagan is President, Interim Chief Financial Officer of the Company. Mr. Lagan was Interim Chief Financial Officer of the Company from September 30, 2016 through May 24, 2017. He was again appointed Interim Chief Financial Officer after the resignation of Michael Pollack effective October 13, 2017. since 2019.
| Age | 54 |
| Tenure | 5 years |
| Phone | 561 855 1626 |
| Web | https://www.rennovahealth.com |
Rennova Health Management Efficiency
The company has return on total asset (ROA) of (0.0862) % which means that it has lost $0.0862 on every $100 spent on assets. This is way below average. Rennova Health's management efficiency ratios could be used to measure how well Rennova Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 15.17 M in liabilities with Debt to Equity (D/E) ratio of 0.81, which is about average as compared to similar companies. Rennova Health has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Rennova Health until it has trouble settling it off, either with new capital or with free cash flow. So, Rennova Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Rennova Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Rennova to invest in growth at high rates of return. When we think about Rennova Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 13 records | CEO Age | ||
| William MBA | OncoCyte Corp | 62 | |
| Timothy Damadian | Fonar | 60 | |
| James Lanthier | Standard Biotools | N/A | |
| Eutillio Buccilli | Genetic Technologies | 63 | |
| Brian Rooyen | Standard Biotools | 53 | |
| BSc III | T2 Biosystms | 61 | |
| Harry Simeonidis | Intelligent Bio Solutions | 57 | |
| Michael West | OncoCyte Corp | 71 | |
| Scott Hutton | BiodesixInc | 52 | |
| Michael Egholm | Standard Biotools | 61 | |
| John McDonough | T2 Biosystms | 57 | |
| Ronald Andrews | OncoCyte Corp | 64 | |
| Emily Leproust | Twist Bioscience Corp | 51 | |
Management Performance
| Return On Asset | -0.0862 |
Rennova Health Leadership Team
Elected by the shareholders, the Rennova Health's board of directors comprises two types of representatives: Rennova Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rennova. The board's role is to monitor Rennova Health's management team and ensure that shareholders' interests are well served. Rennova Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rennova Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Mika, Chairman of the Board | ||
| Christopher Diamantis, Director | ||
| Jonathan Immordino, CFO | ||
| Michael Goldberg, Director | ||
| Seamus Lagan, CEO and President and Director | ||
| Jason Adams, CFO | ||
| Michael Pollack, Interim CFO | ||
| Marlen McLennan, CFO, Vice President - Finance | ||
| Marlene McLennan, CFO, Vice President - Finance | ||
| Karen Taylor, Director HR | ||
| Paul Billings, Director | ||
| Sebastien Sainsbury, CEO of Platinum Financial Solutions Ltd | ||
| Jeffrey Wadman, Controller, Treasurer | ||
| Gary Blum, Independent Director | ||
| Benjamin Frank, Director | ||
| Kristi Dymond, Treasurer | ||
| James Karis, Director | ||
| John Beach, Director | ||
| Robert Lee, Director | ||
| Tiffany VanDeMark, Marketing Director |
Rennova Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Rennova Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0862 | ||||
| Profit Margin | (0.53) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 18.13 M | ||||
| Shares Outstanding | 29.08 B | ||||
| Shares Owned By Institutions | 9.00 % | ||||
| Price To Earning | (0.03) X | ||||
| Price To Sales | 0 X | ||||
| Revenue | 3.22 M | ||||
| Gross Profit | (2.07 M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Rennova Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Rennova Health's short interest history, or implied volatility extrapolated from Rennova Health options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Rennova Pink Sheet
If you are still planning to invest in Rennova Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rennova Health's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |